| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Top7 or 10 Tips > Top 7 Stories Reporters Don't Want to Hear |
|
Just Other Articles - Top 7 Stories Reporters Don't Want to Hear
You’ve decided to make press releases part of your public relations program - Now what? Developing newsworthy material According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product can be tougher than you think. Reporters get barraged with scores of article submissions every day, so they eagerly loo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in k for reasons to ignore them. While nobody can say for sure what the news is, these Top 7 stories definitely are not: lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. #1. Shameless self-promotion, any topic. Reporters have no interest in singing your praises; their job is to inform the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe public. Articles littered with hype flags like “world’s greatest” and “revolutionary new product” go straight to the re d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cycle bin. #2. News blobs. Even if you have actual news, reporters want a sharp angle, not a confused pile of facts. Ar ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc range your information into a story people want to hear. Suppose you’re announcing a newly opened branch office—who care easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ? But if you explain how it created 30 jobs for an economically ravaged community, people will care plenty. #3. Blah, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically blah, blah. Press releases over 650 words have no chance. Ideal is 300-400 words. #4. Better never than late. Do not su and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ bmit stories about an event that will take place the next day. Print and online media need at least 48 hours (often mor ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ) to edit material and prepare layouts. Respect their lead times and reporters will respect you. #5. Announcing! Stori ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a es about new online store openings are so common they have ceased to be news. So unless you have a spectacular angle, p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ut your ramp-up efforts into SEO and PPC. #6. So-and-so got promoted. People get promoted all the time. You need to be cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin able to tell the reporter why this promotion is special, different, and worth taking up valuable space in his publicati tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n. #7. New client! Companies like to brag when they land a big client. Occasionally these events get written up into t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel effective press releases, case studies, and white papers. But typically, the stories sound like self-promotion and neve ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r see the light of day or dark of ink. Remember: reporting and advertising are entirely different disciplines. Adverti y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ers tell why, but reporters need who, what, where and when. Advertisers are partisan and make claims; reporters are obje . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ctive and demand facts. Finally, advertising is eternally optimistic, but a solid news story often contains information elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip that is negative from the company’s point of view. Make sense? If so, pick up your press credentials and start typing tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Find Legitimate Online Jobs Work From Home Opportunities Computer Consulting: Finding Your Prospects Among Your Leads The Highest Form of Persuasion Revealed
|